Exchange: NYSE Sector: Healthcare Industry: Medical - Instruments & Supplies
-1.74% $12.44
America/New_York / 8 mai 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 1 479.01 mill |
EPS: | -0.540 |
P/E: | -23.04 |
Earnings Date: | May 09, 2024 |
SharesOutstanding: | 118.89 mill |
Avg Daily Volume: | 1.275 mill |
RATING 2024-05-08 |
---|
B- |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Buy | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -23.04 | sector: PE 15.43 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.54x |
Company: PE -23.04 | industry: PE 42.42 |
DISCOUNTED CASH FLOW VALUE |
---|
$-4.54 (-136.47%) $-16.98 |
Date: 2024-05-09 |
Expected Trading Range (DAY) |
---|
$ 11.90 - 12.98 ( +/- 4.36%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-11 | Miller Steven Clive | Sell | 24 225 | Class A Common Stock |
2024-03-06 | Gilboa David Abraham | Buy | 52 065 | Class B Common Stock |
2024-03-06 | Gilboa David Abraham | Sell | 28 311 | Class B Common Stock |
2024-03-08 | Gilboa David Abraham | Sell | 52 065 | Class B Common Stock |
2024-03-06 | Gilboa David Abraham | Sell | 44 703 | Restricted Stock Units |
INSIDER POWER |
---|
-30.48 |
Last 100 transactions |
Buy: 896 502 | Sell: 1 952 443 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $12.44 (-1.74% ) |
Volume | 1.339 mill |
Avg. Vol. | 1.275 mill |
% of Avg. Vol | 105.04 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.